Medidata Solutions, Inc. (NASDAQ:MDSO) Earns "Buy" Rating from Citigroup Inc

218,186 shares of the company were exchanged.

Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Tuesday, July 18th. It has outperformed by 51.67% the S&P500.The move comes after 6 months negative chart setup for the $4.56B company. J P Morgan Chase & Co boosted their price target on shares of Medidata Solutions to $87.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 18th. Following the completion of the sale, the chief operating officer now directly owns 171,754 shares of the company's stock, valued at approximately $11,930,032.84. Following the sale, the director now owns 54,372 shares of the company's stock, valued at $3,994,167.12. About 288,984 shares traded. Popular Inc (NASDAQ:BPOP) has risen 26.79% since July 26, 2016 and is uptrending. It has outperformed by 10.25% the S&P500.

Investors sentiment increased to 1.1 in 2016 Q4. Its down 0.26, from 1.23 in 2016Q3. It also reduced Copart Inc (NASDAQ:CPRT) stake by 18,981 shares and now owns 298,667 shares. 32 funds opened positions while 68 raised stakes. With 621,100 avg volume, 7 days are for Medidata Solutions Incorporated (NASDAQ:MDSO)'s short sellers to cover MDSO's short positions. Bnp Paribas Arbitrage Sa has 10,174 shares.

Shares of Medidata Solutions (NASDAQ MDSO) traded up 0.43% on Monday, reaching $77.13. Bancorp Of Mellon has invested 0.01% in Medidata Solutions Inc (NASDAQ:MDSO). California State Teachers Retirement Systems stated it has 113,417 shares. Prudential Fin reported 142,960 shares stake. Vanguard Group Inc. boosted its stake in shares of Medidata Solutions by 5.1% in the first quarter. Glenmede Trust Na holds 0% or 700 shares. State of Alaska Department of Revenue boosted its position in shares of Medidata Solutions by 2.2% in the first quarter. 7,500 shares valued at $420,375 were sold by de Vries Glen Michael on Thursday, March 9. Another trade for 5,639 shares valued at $414,241 was made by TAYLOR ROBERT on Monday, June 5. Capone Michael L sold $280,700 worth of stock. To measure price-variation, we found MDSO's volatility during a week at 4.37% and during a month it has been found around 3.05%. Analysts forecast that Medidata Solutions will post $1.28 EPS for the current fiscal year. (NASDAQ:MDSO) from a buy rating to a hold rating in a research report released on Monday. Therefore 38% are positive.

A number of equities analysts have commented on the stock. As per Friday, June 16, the company rating was maintained by Jefferies. As per Wednesday, October 28, the company rating was maintained by Stifel Nicolaus. The company was upgraded on Friday, February 10 by SunTrust.

02/11/2016 - Medidata Solutions, Inc. had its " rating reiterated by analysts at Deutsche Bank. Finally, Citigroup Inc. reissued a buy rating and issued a $95.00 price objective (up previously from $94.00) on shares of Medidata Solutions in a research note on Monday. On Monday, May 29 the stock rating was maintained by RBC Capital Markets with "Buy". The rating was maintained by Morgan Stanley with "Buy" on Wednesday, June 14.

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. It has a 125.8 P/E ratio. The Business's plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and twelve have assigned a buy rating to the company's stock. The firm has "Hold" rating by Keefe Bruyette & Woods given on Thursday, July 6. The rating was maintained by Topeka Capital Markets with "Buy" on Thursday, February 11. The firm has "Mkt Perform" rating given on Wednesday, January 25 by Keefe Bruyette & Woods. The firm has "Outperform" rating given on Saturday, August 22 by Cowen & Co. BTIG Research downgraded the shares of BPOP in report on Tuesday, November 22 to "Neutral" rating. The rating was maintained by Needham with "Buy" on Friday, February 10. 9,500 were reported by Trexquant Investment Limited Partnership. Moreover, Millennium Management Limited Com has 0.08% invested in Popular Inc (NASDAQ:BPOP). Basswood Mgmt Ltd Liability has 53,325 shares for 0.1% of their portfolio. 117,472 were reported by Blackrock Group Ltd. 79,404 are held by Rhumbline Advisers. Tci Wealth accumulated 27 shares. 11,220 are held by Proshare Advisors Ltd Llc.

Since February 8, 2017, it had 0 insider buys, and 8 selling transactions for $6.62 million activity. NESTOR O. RIVERA also sold $469,674 worth of Popular Inc (NASDAQ:BPOP) on Tuesday, May 2.

As of the end of the quarter Personal Capital Advisors Corp had sold a total of 7,839 shares trimming its holdings by 62.9%. On Wednesday, May 3 SEPULVEDA ELI sold $84,247 worth of Popular Inc (NASDAQ:BPOP) or 1,994 shares.

News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions, Inc. with MarketBeat.com's FREE daily email newsletter.

Latest News